PREDICTORS OF ADVERSE OUTCOME IN CANCER-PATIENTS WITH CANDIDEMIA

Citation
Ej. Anaissie et al., PREDICTORS OF ADVERSE OUTCOME IN CANCER-PATIENTS WITH CANDIDEMIA, The American journal of medicine, 104(3), 1998, pp. 238-245
Citations number
33
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00029343
Volume
104
Issue
3
Year of publication
1998
Pages
238 - 245
Database
ISI
SICI code
0002-9343(1998)104:3<238:POAOIC>2.0.ZU;2-N
Abstract
BACKGROUND: Many factors, including severity of illness, neutropenia, intravenous catheter management, and drug therapy may affect the outco me of candidemia in cancer patients. METHODS: The records of all patie nts at M. D. Anderson Cancer Center who developed one or more positive blood cultures for Candida spp between January 1, 1988, and December 31, 1992, were retrospectively reviewed. Four hundred ninety one episo des of candidemia were identified, for which 476 had complete medical records, which were reviewed in detail. RESULTS: By 3-month follow-up, 52% of the patients had died. Neutropenia, higher APACHE III score, a nd visceral dissemination were associated with poor prognosis. Cure ra tes, adjusted for severity of illness, were similar for fluconazole an d amphotericin B treatment. Exchange of central venous catheters was a ssociated with a modest improvement in prognosis. CONCLUSION: Several factors that influence the outcome of candidemia in cancer patients ha ve been identified. These factors may be relevant for the clinical man agement of cancer patients with candidemia, and for the design of ther apeutic trials.